Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Policy / Regulatory
R&D
CDE Releases Draft Guidelines for Extrapolating Adult Drug Data to Pediatric Use
February 3, 2025
Company
Drug
RemeGen’s Telitacicept Receives FDA Orphan Drug Designation for Myasthenia Gravis
February 3, 2025
Company
Deals
Jacobio Partners with Merck KGaA for KRAS G12C Inhibitor Clinical Study
February 3, 2025
Company
Medical Device
Hotgen Biotech Gains Regulatory Approvals in Saudi Arabia and India
February 3, 2025
Company
Drug
BeiGene’s Brukinsa Outperforms Imbruvica in Phase III ALPINE Study
February 3, 2025
Company
Hengrui Medicine’s Deputy GM Tao Weikang Resigns, Joins Qilu Pharma
February 3, 2025
Company
Deals
Proxinse Medtech Raises Series A Funding for Endoscope Camera System
February 3, 2025
Company
Deals
AlphaLife Sciences Raises Series A+ Funding for Clinical Research SaaS
February 3, 2025
Company
Drug
Aosaikang’s Neratinib Maleate API Market Filing Accepted by NMPA
February 3, 2025
Drug
Policy / Regulatory
Azvudine Included in China’s COVID-19 Treatment Protocol
February 3, 2025
Company
Drug
NMPA Approves IND Filing for Henan Genuine Biotech’s Long-Acting HIV Drug CL-197
February 3, 2025
Company
Deals
WuXi Biologics Partners with Toregem BioPharma on Anti-USAG-1 Monoclonal Antibody
February 3, 2025
1
2
…
1,122
1,123
1,124
1,125
1,126
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?